Per Nexonav EC tab Esomeprazole Mg trihydrate. Per Nexonav IV inj Esomeprazole Na
Indications/Uses
Nexonav PUD & other conditions where inhibition of gastric acid secretion may be beneficial including aspiration syndrome, healing of erosive esophagitis, dyspepsia, GERD & Zollinger-Ellison syndrome. Nexonav IV Short-term treatment (up to 10 days) of GERD patients w/ a history of erosive esophagitis as an alternative to oral therapy in patients when therapy w/ esomeprazole EC tab is not possible or appropriate. Treatment of PUD & NSAID-associated ulceration in GERD & Zollinger-Ellison syndrome.
Nexonav EC tabAdult 1-2 EC tab once daily. Dyspepsia 10 or 20 mg daily for 2-4 wk. GERD 20-40 mg once daily for 4-12 wk or max daily dose of 40 mg for 4-12 wk. Erosive reflux esophagitis 40 mg once daily for 4 wk. PUD 20 mg once daily or 40 mg daily in severe cases, may be continued for 4 wk (for duodenal ulcer) & 8 wk (for gastric ulcer). Maintenance: 10-20 mg once daily. Zollinger-Ellison syndrome Initially 40 mg bid, may be increased to 80-160 mg daily in divided doses or bid. NSAID-associated ulceration 20 mg daily. Nexonav IV injGERD w/ history of erosive esophagitisAdult 20 or 40 mg once daily by IV inj (not <3 min) or infusion (10-30 min) once daily.
Nexonav May interfere w/ antiretroviral drugs & drugs affected by gastric pH changes. Not recommended in pregnancy. Nexonav IV Pregnancy & lactation. Childn. Elderly.
A02BC05 - esomeprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
Sign Out
